Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 February 2008, Vol. 111, No. 3, pp. 1182-1192.
Prepublished online as a Blood First Edition Paper on November 1, 2007; DOI 10.1182/blood-2007-04-083600.


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Figure
Right arrow All Versions of this Article:
blood-2007-04-083600v1
111/3/1182    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cheng, J. C.
Right arrow Articles by Sakamoto, K. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cheng, J. C.
Right arrow Articles by Sakamoto, K. M.
Related Collections
Right arrow Hematopoiesis and Stem Cells
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

HEMATOPOIESIS

CREB is a critical regulator of normal hematopoiesis and leukemogenesis

Jerry C. Cheng1,2, Kentaro Kinjo1,2, Dejah R. Judelson1,2, Jenny Chang1,2, Winston S. Wu1,2, Ingrid Schmid3, Deepa B. Shankar4, Noriyuki Kasahara5, Renata Stripecke5, Ravi Bhatia6, Elliot M. Landaw7, and Kathleen M. Sakamoto1,2,5,8

1 Division of Hematology/Oncology, Department of Pediatrics, Gwynne Hazen Cherry Memorial Laboratories and Mattel Children's Hospital, Jonsson Comprehensive Cancer Center; 2 Division of Hematology/Oncology, Jonsson Comprehensive Cancer Center; 3 UCLA Flow Cytometry Core Facility, Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at University of California at Los Angeles; 4 Discovery Biology, Jubilant Biosystems, Bangalore, India; 5 Molecular Biology Institute, University of California at Los Angeles; 6 Department of Hematopoietic Stem Cell and Leukemia Biology, City of Hope, Duarte, CA; 7 Department of Biomathematics, University of California at Los Angeles; 8 Division of Biology, California Institute of Technology, Pasadena

The cAMP-responsive element binding protein (CREB) is a 43-kDa nuclear transcription factor that regulates cell growth, memory, and glucose homeostasis. We showed previously that CREB is amplified in myeloid leukemia blasts and expressed at higher levels in leukemia stem cells from patients with myeloid leukemia. CREB transgenic mice develop myeloproliferative disease after 1 year, but not leukemia, suggesting that CREB contributes to but is not sufficient for leukemogenesis. Here, we show that CREB is most highly expressed in lineage negative hematopoietic stem cells (HSCs). To understand the role of CREB in hematopoietic progenitors and leukemia cells, we examined the effects of RNA interference (RNAi) to knock down CREB expression in vitro and in vivo. Transduction of primary HSCs or myeloid leukemia cells with lentiviral CREB shRNAs resulted in decreased proliferation of stem cells, cell- cycle abnormalities, and inhibition of CREB transcription. Mice that received transplants of bone marrow transduced with CREB shRNA had decreased committed progenitors compared with control mice. Mice injected with Ba/F3 cells expressing either Bcr-Abl wild-type or T315I mutation with CREB shRNA had delayed leukemic infiltration by bioluminescence imaging and prolonged median survival. Our results suggest that CREB is critical for normal myelopoiesis and leukemia cell proliferation.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
K. M. Sakamoto and D. A. Frank
CREB in the Pathophysiology of Cancer: Implications for Targeting Transcription Factors for Cancer Therapy
Clin. Cancer Res., April 15, 2009; 15(8): 2583 - 2587.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Pigazzi, E. Manara, E. Baron, and G. Basso
miR-34b Targets Cyclic AMP-Responsive Element Binding Protein in Acute Myeloid Leukemia
Cancer Res., March 15, 2009; 69(6): 2471 - 2478.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2008 by American Society of Hematology         Online ISSN: 1528-0020